A Multicenter Retrospective Cohort Study to investigate the clinical significance of CA125 in the posterior line chemotherapy for unresectable advanced/recurrent colorectal cancer.
Not Applicable
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000040059
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Hokkaido University Hospital
- Brief Summary
In this retrospective analysis, baseline CA125 correlated with ascites volume in later line treatment of patients with mCRC, suggesting that increased CA125 may be a predictive and prognostic factor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
1)Participation in the clinical trial is determined as unsuitable.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival
- Secondary Outcome Measures
Name Time Method Overall Survival, Response rate, Disease control rate, Search for treatment effect predictor and prognostic predictors, treatment effect on ascites